CurrentUnitedHealthcarePolicy CS2026D0073G

Self-Administered Medications (Medical Benefit Drug Policy)

Defines UnitedHealthcare's medical benefit coverage stance for self‑administered medications and identifies factors used to determine when a drug is considered self‑administered and therefore not reimbursed under medical benefit plans. Affects providers submitting medical benefit claims and members under UnitedHealthcare standard benefit plans.

Policy Summary

PayerUnitedHealthcare

PolicySelf-Administered Medications (Medical Benefit Drug Policy)

Policy CodePolicy CS2026D0073G

Change TypeRemoval of state-specific exclusionsarchival of prior versions

Effective DateApril 1, 2026

Next Review Date

Key ActionRefer to the Self‑Administered Medications List for applicable HCPCS/HCPCS-like codes when submitting medical benefit claims.

SourceLink

POLICY UPDATE CHANGES

Removed language indicating this Medical Benefit Drug Policy does not apply to the state of Indiana.

Removed content/language pertaining to the state of Louisiana.

Archived previous policy versions CS2025D0073F and CSIND0073.03.

1pages

NCstate referenced

0637revenue code

Apr 1, 2026effective

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria — Self‑Administered Determination

Self‑Administered Determination Criteria

Medications are considered self‑administered and not reimbursed on medical benefit plans when ALL of the following are met:

Self‑administered determination: Medication is not typically administered or directly supervised by a qualified provider or licensed/certified health professional in an outpatient setting; and medication does not require continuous or periodic monitoring immediately before, during, or after administration by a qualified provider or licensed/certified health professional in an outpatient setting; and route of administration is consistent with self‑administration (e.g., oral, inhaled, intranasal, topical, rectal, subcutaneous, or self‑injectable intramuscular injections); and dosage form is consistent with self‑administration (e.g., prefilled syringe, auto‑injector, tablet, capsule, suppository, nasal spray, metered dose inhaler, nebulized solution); and acuity of condition is consistent with self‑administration (e.g., chronic disease); and frequency of administration is consistent with self‑administration; and standards of medical practice allow self‑administration (e.g., self‑infused hemophilia factor).

Determination uses evaluation of FDA labeling, manufacturer literature, peer‑reviewed literature, guidelines, utilization statistics, and compendia.

Any clinician‑administered dosage formulations of drugs listed on the Self‑Administered Medications List (for example, intravenous infusions) may be considered separately for coverage and may be covered under the medical benefit. Providers should reference the Self‑Administered Medications List when determining whether a given HCPCS/HCPCS‑like code represents a self‑administered formulation or a clinician‑administered formulation that could be billed to the medical benefit.

Medications that meet the policy’s self‑administered determination are not reimbursed on medical benefit plans. Determination uses factors such as route and dosage form, monitoring requirements, acuity and frequency of administration, and standards of medical practice; see the Self‑Administered Medications List for applicable codes and clinical details.

Coding — Revenue and Billing Codes

Applicable Revenue Code for Self-Administered DrugsRevenue

0637	Self-administered drugs (use this revenue code for self-administered drugs not requiring detailed coding)

Provider Actions and Billing Guidance

Prior Authorization

Code Reference for Prior Authorization/Coverage

Refer to the Self‑Administered Medications List for applicable HCPCS/HCPCS‑like codes when determining prior authorization or coverage requirements for medications identified as self‑administered.

See Self‑Administered Medications List for HCPCS/HCPCS‑like codes
Revenue code 0637 may be used for self‑administered drugs not requiring detailed coding

Note

Use of Third‑Party Tools to Assist Benefits Administration

UnitedHealthcare may use third‑party tools (for example, InterQual®) to assist in administering health benefits; providers should follow plan‑specific requirements and any applicable tool determinations when submitting requests.

Follow plan requirements and any determinations from third‑party tools
Third‑party tool use is for benefit administration assistance, not a substitute for plan or contractual requirements

Background

Patient‑administered medications are those administered by the patient without direct supervision by a qualified provider or licensed/certified health professional. When a medication does not require continuous or periodic monitoring immediately before, during, or after administration and the route and dosage form are consistent with self‑administration (for example, oral, inhaled, intranasal, topical, rectal, subcutaneous, or self‑injectable forms), the drug is typically classified as self‑administered and excluded from medical benefit reimbursement. The policy’s determination also considers FDA labeling, manufacturer literature, peer‑reviewed evidence, guidelines, utilization statistics, and compendia.

Definitions

Self‑administered medications — definition and distinguishing characteristics

DefinitionMedications not typically administered or directly supervised by a qualified provider or licensed/certified health professional in an outpatient setting and that do not require continuous or periodic monitoring immediately before, during, or after administration.

Common routes consistent with self‑administrationOral, inhaled, intranasal, topical, rectal, subcutaneous, or self‑injectable intramuscular injections.

Common dosage forms consistent with self‑administrationPrefilled syringes, auto‑injectors, tablets, capsules, suppositories, nasal sprays, metered dose inhalers, nebulized solutions.

Clinical context / acuityTypically used for conditions with acuity and frequency consistent with self‑administration (e.g., chronic disease); standards of medical practice must allow self‑administration (e.g., self‑infused hemophilia factor).

Determination sourcesEvaluation uses FDA prescribing information, manufacturer literature, peer‑reviewed literature, evidence‑based guidelines, utilization statistics, and compendia (e.g., DRUGDEX, Clinical Pharmacology).

Site of Care Considerations

Note

Infusion center — clinician‑administered formulations may be covered

Medications that are clinician‑administered (for example, IV infusions) may be covered under the medical benefit even if the drug appears on the Self‑Administered Medications List in self‑administered form.

Submit claims for clinician‑administered formulations under the medical benefit as appropriate.